Lv1
50 积分 2023-04-21 加入
Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies
14天前
已完结
Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer
22天前
已完结
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoring
26天前
已完结
Role of Microglial Dysfunction in Parkinson’s Disease: From Multifactorial Causes to Neurodegeneration
1个月前
已完结
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with/without olaparib in endometrial cancer: Biomarkers, histological heterogeneity, baseline circulating tumor DNA and efficacy in the DUO-E mismatch repair proficient subpopulation
1个月前
已完结
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with/without olaparib in endometrial cancer: Biomarkers, histological heterogeneity, baseline circulating tumor DNA and efficacy in the DUO-E mismatch repair proficient subpopulation
1个月前
已完结
Pan-cancer spatial atlas of tertiary lymphoid structures
1个月前
已完结
Advances in the management of localized bladder cancers
2个月前
已完结
Multi-omics profiling distinguishes sebaceous carcinoma from benign sebaceous neoplasms and provides insight into the genetic evolution of sebaceous carcinogenesis
2个月前
已完结
Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma
2个月前
已完结
皖公网安备34019202002308
